16-2461124-G-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_025108.3(TEDC2):āc.505G>Cā(p.Gly169Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000695 in 1,568,184 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_025108.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TEDC2 | NM_025108.3 | c.505G>C | p.Gly169Arg | missense_variant | 4/10 | ENST00000361837.9 | NP_079384.2 | |
TEDC2 | XM_011522667.2 | c.406G>C | p.Gly136Arg | missense_variant | 3/9 | XP_011520969.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TEDC2 | ENST00000361837.9 | c.505G>C | p.Gly169Arg | missense_variant | 4/10 | 1 | NM_025108.3 | ENSP00000355022.4 |
Frequencies
GnomAD3 genomes AF: 0.000407 AC: 62AN: 152234Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000110 AC: 23AN: 209042Hom.: 0 AF XY: 0.0000617 AC XY: 7AN XY: 113398
GnomAD4 exome AF: 0.0000332 AC: 47AN: 1415832Hom.: 1 Cov.: 33 AF XY: 0.0000243 AC XY: 17AN XY: 699066
GnomAD4 genome AF: 0.000407 AC: 62AN: 152352Hom.: 0 Cov.: 33 AF XY: 0.000362 AC XY: 27AN XY: 74500
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 17, 2021 | The c.505G>C (p.G169R) alteration is located in exon 4 (coding exon 4) of the C16orf59 gene. This alteration results from a G to C substitution at nucleotide position 505, causing the glycine (G) at amino acid position 169 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at